SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-001295
Filing Date
2013-03-18
Accepted
2013-03-18 16:09:27
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT immy_10k.htm 10-K 2140723
2 CONSENT immy_ex231.htm EX-23.1 3524
3 CERTIFICATION immy_ex311.htm EX-31.1 19579
4 CERTIFICATION immy_ex312.htm EX-31.2 19684
5 CERTIFICATION immy_ex321.htm EX-32.1 7845
6 img001.jpg GRAPHIC 35906
  Complete submission text file 0001354488-13-001295.txt   5946064

Data Files

Seq Description Document Type Size
7 immy-20121231.xml EX-101.INS 656940
8 immy-20121231.xsd EX-101.SCH 39807
9 immy-20121231_cal.xml EX-101.CAL 59815
10 immy-20121231_def.xml EX-101.DEF 62506
11 immy-20121231_lab.xml EX-101.LAB 285777
12 immy-20121231_pre.xml EX-101.PRE 188709
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 13697734
SIC: 2834 Pharmaceutical Preparations